Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04518930 |
Other study ID # |
HF vs HP-8/2020 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 1, 2020 |
Est. completion date |
October 22, 2023 |
Study information
Verified date |
March 2024 |
Source |
Al-Balqa Applied University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study will investigate the effects of high-protein, high-fat snacks, specifically Greek
yogurt, and peanuts, on satiety, gut hormones, and insulin secretion in overweight and obese
women. The hypothesis posited that peanuts will exhibit a more beneficial impact on satiety,
gut hormones, and insulin levels compared to Greek yogurt. The two-arm parallel randomized
trial will involve 52 participants aged 30 to 40 with a BMI between 25-35 kg/m²,and they will
be randomly divided into peanut (n=26) and Greek yogurt (n=26) groups. Pre-snack, BMI and
dietary intake will be assessed. Appetite sensations will be gauged using a visual analog
scale (VAS) upon arrival, and at 30- and 60-minutes post-snack. Pre- and post-snacking,
plasma levels of cholecystokinin (CCK), Peptide Tyrosine-Tyrosine (PYY), Glucagon Like
Peptide-1 (GLP-1), Ghrelin (GHRL), and insulin will be analyzed.
Description:
The study's inclusion criteria will be encompassed women aged between 30 and 40 years, with a
body mass index (BMI) ranging from 25 to 35 kg/m². These individuals engaged in light
exercise 1-3 times per week (activity factor 1.375) and adhered to a routine of consuming
three regular meals, along with two daily snacks, and maintaining a water intake of eight
cups and do not have allergies to nuts or yogurt.
All participants should adhere to a 1200 kcal diet plan, which included breakfast, snack 1,
lunch, snack 2, and dinner. This diet plan will remain consistent for all participants over a
consecutive three-day period, except for the snacks that will be provided during the second
visit. The specific snack assigned to each participant will be determined based on a
predetermined randomization list. The first experimental group (n=26) will receive a
high-protein snack in the form of plain Greek yogurt, while the second experimental group
(n=26) will receive a high-fat snack in the form of peanuts.
Prior to intervention, in the first visit all anthropometric and body composition assessments
will be performed. On the second visit which will be scheduled after three days of adhering
to the 1200 Kcal diet, all participants should arrive at the clinic at 1:00 pm and they
should had their breakfast at home at 9:00 am. Upon arrival, a baseline blood samples from
each participant will be collected.
At 1:00 pm, participants in the plain Greek yogurt and peanut groups will consume their
assigned snacks. Following snack consumption, a validated visual analog scale (VAS)
questionnaire will be distributed to assess sensations and appetite levels at 0 minutes (1:00
pm), 30 minutes (1:30 pm), and 60 minutes (2:00 pm).
One hour after their arrival, at 2:00 pm, a second blood sample will be collected from all
participants. Serum samples will be used to analyze the Ghrelin, PYY, CCK, Glp-1 and insulin
using human ELISA kits.
Statistical analysis will be performed after data entry using the SPSS statistical software.
Prior to analysis data will be tested for normality. Descriptive statistics for continuous
(means± SD) and categorical variables (frequencies and percentages) along with analytical
statistics including t-test for paired and unpaired means and the repeated measures for the
general linear model will be performed too. P < 0.05 will consider significant.